- Home
- HROW vs LZB Comparison
HROW vs LZB Comparison
Compare HROW & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HROW
- LZB
- Stock Information
- Founded
- HROW 1998
- LZB 1927
- Country
- HROW United States
- LZB United States
- Employees
- HROW N/A
- LZB N/A
- Industry
- HROW Biotechnology: Pharmaceutical Preparations
- LZB Home Furnishings
- Sector
- HROW Health Care
- LZB Consumer Discretionary
- Exchange
- HROW Nasdaq
- LZB Nasdaq
- Market Cap
- HROW 1.4B
- LZB 1.3B
- IPO Year
- HROW N/A
- LZB N/A
- Fundamental
- Price
- HROW $36.81
- LZB $32.15
- Analyst Decision
- HROW Strong Buy
- LZB Buy
- Analyst Count
- HROW 7
- LZB 1
- Target Price
- HROW $68.50
- LZB $46.00
- AVG Volume (30 Days)
- HROW 804.0K
- LZB 434.5K
- Earning Date
- HROW 11-10-2025
- LZB 11-18-2025
- Dividend Yield
- HROW N/A
- LZB 2.65%
- EPS Growth
- HROW N/A
- LZB N/A
- EPS
- HROW N/A
- LZB 2.18
- Revenue
- HROW $227,661,000.00
- LZB $2,105,904,000.00
- Revenue This Year
- HROW $43.92
- LZB $2.12
- Revenue Next Year
- HROW $41.22
- LZB $4.04
- P/E Ratio
- HROW N/A
- LZB $14.81
- Revenue Growth
- HROW 47.69
- LZB 2.18
- 52 Week Low
- HROW $20.85
- LZB $31.42
- 52 Week High
- HROW $54.19
- LZB $48.31
- Technical
- Relative Strength Index (RSI)
- HROW 38.13
- LZB 40.57
- Support Level
- HROW $36.20
- LZB $32.08
- Resistance Level
- HROW $39.77
- LZB $33.50
- Average True Range (ATR)
- HROW 1.89
- LZB 0.65
- MACD
- HROW -0.40
- LZB 0.10
- Stochastic Oscillator
- HROW 9.98
- LZB 29.43
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.